Verified Sponsor Execution & Regulatory Ledger
| Sponsor Metric | Verified Count / Rate |
|---|---|
| Phase II & III Protocols (2018 to 2026) | 44 |
| Active Pipeline (Recruiting Now) | 26 (13) |
| Completed vs Stopped Early | 8 / 2 (4.5%) |
| Median Closed Actual Enrollment | 60 participants |
| Physical Hospital Site Disclosure | 100.0% named hospitals |
| FDA Drugs@FDA Original NDA/BLA Approvals | 0 (0 since 2018) |
Indexed Multi-Center Phase II & III Protocols
| NCT Identifier | Protocol Brief Title | Phase | Status |
|---|---|---|---|
| NCT07116733 | Desflurane vs. Propofol for Cardiac Anesthesia | Phase III | RECRUITING |
Explore interactive annual charts and M&A subsidiary rollups in the Xijing Hospital Interactive Dossier, benchmark peers in Oncology and Hematology, or review the Healthcare Price & Patent Cliff Crosswalk.